(HNI) HNI - Overview
Sector: Consumer CyclicalIndustry: Furnishings, Fixtures & Appliances | Exchange NYSE (USA) | Currency USD | Market Cap: 2.475m | Total Return -20% in 12m
Stock: Workplace Furniture, Fireplaces, Hearth Products
Total Rating 37
Risk 55
Buy Signal -0.91
| Risk 5d forecast | |
|---|---|
| Volatility | 30.7% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -33.93 |
| Character TTM | |
|---|---|
| Beta | 1.158 |
| Beta Downside | 1.174 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.55% |
| CAGR/Max DD | 0.28 |
EPS (Earnings per Share)
Revenue
Description: HNI HNI March 05, 2026
HNI Corporation manufactures and markets workplace furnishings and residential building products. The company operates in the United States and Canada.
The Workplace Furnishings segment provides a range of office furniture, including systems, seating, and storage. This segment utilizes multiple sales channels, such as independent dealers, wholesalers, and direct sales to end-users. The office furniture sector is cyclical, often correlating with corporate capital expenditure trends.
The Residential Building Products segment offers fireplaces and related accessories. Products are sold under various brands through independent dealers, distributors, and company-owned outlets. The residential building products market is influenced by housing starts and renovation activity.
HNI Corporation, founded in 1944, is headquartered in Muscatine, Iowa. Further analysis of HNIs financial performance and market position is available on ValueRay.
Headlines to watch out for
- Office furniture demand impacts Workplace Furnishings segment revenue
- Residential construction starts drive fireplace sales
- Raw material costs influence profit margins
- E-commerce growth expands distribution channels
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 54.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -5.08 > 1.0 |
| NWC/Revenue: 9.60% < 20% (prev 1.86%; Δ 7.74% < -1%) |
| CFO/TA 0.06 > 3% & CFO 276.2m > Net Income 54.1m |
| Net Debt (1.42b) to EBITDA (273.2m): 5.21 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.1m) vs 12m ago -2.89% < -2% |
| Gross Margin: 40.91% > 18% (prev 0.40%; Δ 4.05k% > 0.5%) |
| Asset Turnover: 84.00% > 50% (prev 134.7%; Δ -50.74% > 0%) |
| Interest Coverage Ratio: 3.56 > 6 (EBITDA TTM 273.2m / Interest Expense TTM 35.5m) |
Altman Z'' 1.22
| A: 0.06 (Total Current Assets 1.41b - Total Current Liabilities 1.14b) / Total Assets 4.88b |
| B: 0.12 (Retained Earnings 590.4m / Total Assets 4.88b) |
| C: 0.04 (EBIT TTM 126.5m / Avg Total Assets 3.38b) |
| D: 0.19 (Book Value of Equity 593.9m / Total Liabilities 3.05b) |
| Altman-Z'' Score: 1.22 = BB |
Beneish M -2.06
| DSRI: 2.04 (Receivables 571.1m/249.6m, Revenue 2.84b/2.53b) |
| GMI: 0.97 (GM 40.91% / 39.86%) |
| AQI: 1.16 (AQ_t 0.42 / AQ_t-1 0.37) |
| SGI: 1.12 (Revenue 2.84b / 2.53b) |
| TATA: -0.05 (NI 54.1m - CFO 276.2m) / TA 4.88b) |
| Beneish M-Score: -2.06 (Cap -4..+1) = BB |
What is the price of HNI shares?
As of March 30, 2026, the stock is trading at USD 34.38 with a total of 479,222 shares traded.
Over the past week, the price has changed by -6.19%, over one month by -22.95%, over three months by -18.95% and over the past year by -20.00%.
Over the past week, the price has changed by -6.19%, over one month by -22.95%, over three months by -18.95% and over the past year by -20.00%.
Is HNI a buy, sell or hold?
HNI has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy HNI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HNI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72 | 109.4% |
| Analysts Target Price | 72 | 109.4% |
HNI Fundamental Data Overview March 30, 2026
P/E Trailing = 30.973
P/E Forward = 8.4388
P/S = 0.8718
P/B = 1.3484
P/EG = 0.4218
Revenue TTM = 2.84b USD
EBIT TTM = 126.5m USD
EBITDA TTM = 273.2m USD
Long Term Debt = 1.28b USD (from longTermDebt, last quarter)
Short Term Debt = 123.0m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 3.89b USD (2.48b + Debt 1.63b - CCE 215.7m)
Interest Coverage Ratio = 3.56 (Ebit TTM 126.5m / Interest Expense TTM 35.5m)
EV/FCF = 18.49x (Enterprise Value 3.89b / FCF TTM 210.4m)
FCF Yield = 5.41% (FCF TTM 210.4m / Enterprise Value 3.89b)
FCF Margin = 7.41% (FCF TTM 210.4m / Revenue TTM 2.84b)
Net Margin = 1.91% (Net Income TTM 54.1m / Revenue TTM 2.84b)
Gross Margin = 40.91% ((Revenue TTM 2.84b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 40.92% (prev 42.13%)
Tobins Q-Ratio = 0.80 (Enterprise Value 3.89b / Total Assets 4.88b)
Interest Expense / Debt = 1.02% (Interest Expense 16.7m / Debt 1.63b)
Taxrate = 40.20% (36.5m / 90.8m)
NOPAT = 75.6m (EBIT 126.5m * (1 - 40.20%))
Current Ratio = 1.24 (Total Current Assets 1.41b / Total Current Liabilities 1.14b)
Debt / Equity = 0.89 (Debt 1.63b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 5.21 (Net Debt 1.42b / EBITDA 273.2m)
Debt / FCF = 6.76 (Net Debt 1.42b / FCF TTM 210.4m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.60% (Net Income 54.1m / Total Assets 4.88b)
RoE = 5.05% (Net Income TTM 54.1m / Total Stockholder Equity 1.07b)
RoCE = 5.39% (EBIT 126.5m / Capital Employed (Equity 1.07b + L.T.Debt 1.28b))
RoIC = 4.48% (NOPAT 75.6m / Invested Capital 1.69b)
WACC = 6.31% (E(2.48b)/V(4.11b) * Re(10.06%) + D(1.63b)/V(4.11b) * Rd(1.02%) * (1-Tc(0.40)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.63%
[DCF] Terminal Value 87.35% ; FCFF base≈196.7m ; Y1≈242.6m ; Y5≈414.0m
[DCF] Fair Price = 131.3 (EV 10.88b - Net Debt 1.42b = Equity 9.45b / Shares 72.0m; r=6.31% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 47.01 | EPS CAGR: 27.88% | SUE: -0.56 | # QB: 0
Revenue Correlation: 61.93 | Revenue CAGR: 12.44% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.14 | Chg7d=+0.153 | Chg30d=+0.077 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=4.08 | Chg7d=+0.063 | Chg30d=+0.063 | Revisions Net=+1 | Growth EPS=+18.0% | Growth Revenue=+115.9%
EPS next Year (2027-12-31): EPS=4.87 | Chg7d=-0.118 | Chg30d=-0.118 | Revisions Net=-1 | Growth EPS=+19.2% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 10.1% - Earnings Yield 3.2%)
[Growth] Growth Spread = +124.2% (Analyst 131.0% - Implied 6.8%)
P/E Forward = 8.4388
P/S = 0.8718
P/B = 1.3484
P/EG = 0.4218
Revenue TTM = 2.84b USD
EBIT TTM = 126.5m USD
EBITDA TTM = 273.2m USD
Long Term Debt = 1.28b USD (from longTermDebt, last quarter)
Short Term Debt = 123.0m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 3.89b USD (2.48b + Debt 1.63b - CCE 215.7m)
Interest Coverage Ratio = 3.56 (Ebit TTM 126.5m / Interest Expense TTM 35.5m)
EV/FCF = 18.49x (Enterprise Value 3.89b / FCF TTM 210.4m)
FCF Yield = 5.41% (FCF TTM 210.4m / Enterprise Value 3.89b)
FCF Margin = 7.41% (FCF TTM 210.4m / Revenue TTM 2.84b)
Net Margin = 1.91% (Net Income TTM 54.1m / Revenue TTM 2.84b)
Gross Margin = 40.91% ((Revenue TTM 2.84b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 40.92% (prev 42.13%)
Tobins Q-Ratio = 0.80 (Enterprise Value 3.89b / Total Assets 4.88b)
Interest Expense / Debt = 1.02% (Interest Expense 16.7m / Debt 1.63b)
Taxrate = 40.20% (36.5m / 90.8m)
NOPAT = 75.6m (EBIT 126.5m * (1 - 40.20%))
Current Ratio = 1.24 (Total Current Assets 1.41b / Total Current Liabilities 1.14b)
Debt / Equity = 0.89 (Debt 1.63b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 5.21 (Net Debt 1.42b / EBITDA 273.2m)
Debt / FCF = 6.76 (Net Debt 1.42b / FCF TTM 210.4m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.60% (Net Income 54.1m / Total Assets 4.88b)
RoE = 5.05% (Net Income TTM 54.1m / Total Stockholder Equity 1.07b)
RoCE = 5.39% (EBIT 126.5m / Capital Employed (Equity 1.07b + L.T.Debt 1.28b))
RoIC = 4.48% (NOPAT 75.6m / Invested Capital 1.69b)
WACC = 6.31% (E(2.48b)/V(4.11b) * Re(10.06%) + D(1.63b)/V(4.11b) * Rd(1.02%) * (1-Tc(0.40)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.63%
[DCF] Terminal Value 87.35% ; FCFF base≈196.7m ; Y1≈242.6m ; Y5≈414.0m
[DCF] Fair Price = 131.3 (EV 10.88b - Net Debt 1.42b = Equity 9.45b / Shares 72.0m; r=6.31% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 47.01 | EPS CAGR: 27.88% | SUE: -0.56 | # QB: 0
Revenue Correlation: 61.93 | Revenue CAGR: 12.44% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.14 | Chg7d=+0.153 | Chg30d=+0.077 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=4.08 | Chg7d=+0.063 | Chg30d=+0.063 | Revisions Net=+1 | Growth EPS=+18.0% | Growth Revenue=+115.9%
EPS next Year (2027-12-31): EPS=4.87 | Chg7d=-0.118 | Chg30d=-0.118 | Revisions Net=-1 | Growth EPS=+19.2% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 10.1% - Earnings Yield 3.2%)
[Growth] Growth Spread = +124.2% (Analyst 131.0% - Implied 6.8%)